HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing In Brief

This article was originally published in The Rose Sheet

Executive Summary

Decleor: Slimming Aromatherapy range will launch in March, supported by in-store promotions and dedicated training, firm says. Products contain a blend of basil, grapefruit, black pepper, hyssop and clary sage oils, which "triggers the fat breakdown process," Decleor claims. Aromessence Contour ($62) "activates draining to filter stubborn fatty areas," according to the company. Expert Contour ($51) is the second step in the regimen, designed to intensify fat breakdown and prevent new fat masses, the firm says. Contour Balm ($45) reduces the appearance of dimpled skin. Products will be available in 80 Sephora doors, 17 Nordstrom stores and over 600 spas in U.S. Firm also is launching Anti-Wrinkle Defense Sun Protection Sun Cream SPF 15, which will retail for $29 at Barneys, on Sephora.com and in spas and salons...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011907

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel